Sale, License or Hybrid: What is Better For a Medical Patent? It depends On You!

Medical Patents Broker Inc.
By Kenneth Pearce, President

For years, the solo inventor/owner of a medical patent has dreamed of profiting from their invention. Out of nowhere, discussions with a third party have started. But what is better: a straight-up sale, a hybrid, or a straight-up license? Let’s assume the owner’s target price for a sale is $1,000,000.

1. The Straight Asset Sale: Money Now Is Better Than Money Later

The seller receives a lump sum transfer of $1,000,000. * MPB Suggestion: Tell your bank $1MM is coming. If you don’t, the digital “fraud flags” could increase your heart rate and respiration more than the excitement of the deal!

• Estimated Federal Taxation: Taxed as long-term Capital Gains. At $1MM, you face a 20% federal rate plus the 3.8% Net Investment Income Tax (NIIT).
• Guesstimated Net: Roughly $762,000 (before state and local taxes).

2. The Hybrid Deal: More Money Is Better Than Some Money

Hybrids include upfront cash and payments for future performance. To yield a similar net of $762,000, a deal could look like:

• $250,000 Upfront: Often taxed at the lower capital gain rate if structured as an asset purchase.
• $250,000 Milestone: Paid upon 510(k), Phase III, or BLA clearance. Likely treated as Ordinary Income.
• 5% Royalty: On a product with gross sales of $3MM/year.
• Passive Ordinary Income Maybe: Likely treated as passive ordinary income. Depending on IRS classification could be just ordinary income.
• The Result: The $1M gross mark can be reached in about 3 years if sales are strong.
• MPB Suggestion: Always include a Minimum Annual Royalty and a Reversion Clause. If the licensee stalls or sits on inventory after FDA certification, you need the right to take your patent back.

3. The Straight License: Using Other People’s Money

No upfront wire. No need to call the bank yet. Royalties generally range from 3% to 9%. In this example, we use 5%.

• The Tax Bite: Generally Ordinary Income. In 2026, success can push you into the 32% or 37% brackets.
• The Math: To net that same $762,000 after federal taxes, you need to gross about $1.2 Million in royalties to cover the higher tax rates.
• The Future: If the product hits $5M in sales per year, you surpass the $1MM sale price quickly. By the time the patent expires in 12 years, your gross total could be $3,000,000.
• MPB Suggestion: Again, the Reversion Clause is needed for your protection against a licensee who doesn't perform.

The President’s Viewpoint

One person’s treasure is another’s junk. As a broker, clients ask for my opinion on which path is “best.” It is not my job to tell the client what to do, but rather to show them some possibilities.

Personally, I’ve selected all three at different times. My decisions at MPB always include looking in two or more directions at once. We must move forward and wait to see if the selected direction was correct. And hopefully those decisions will orchestrate the technology to the patient sooner rather than later.